In the aftermath of globalization, India's pharmaceutical industry has undergone a remarkable transformation, marked by the ascendancy of third-party pharma manufacturing. Post the liberalization policies of the 1990s, the sector witnessed a paradigm shift, embracing international collaborations and global market outreach. Third-party pharma manufacturing emerged as a strategic response, allowing Indian companies to focus on core competencies while outsourcing manufacturing processes. The evolution is underscored by adherence to stringent international quality standards, technological advancements, and diversified product portfolios. One of the significant developments is the industry's commitment to regulatory compliance, aligning with global standards set by entities like the FDA and WHO. The adoption of cutting-edge technologies and the establishment of state-of-the-art facilities have heightened manufacturing efficiency and product quality. In this era of global partners...
Comments
Post a Comment